Anna Kushnir
Senior VP, Preclinical Development, Vaccines at Codagenix, Inc. - South Farmingdale, NY, US
Anna Kushnir's Colleagues at Codagenix, Inc.
Anna Kushnir's Contact Details
631-227-3932
Washington, District of Columbia, United States
Codagenix, Inc.
Anna Kushnir's Company Details
Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development. Codagenix uses a computer-based algorithm, called SAVE (Synthetic Attenuated Virus Engineering) to design viral genomes that are identical to the wild type strain at the amino acid level, but make less protein in human cells. The highly attenuated viruses make excellent vaccines or oncolytics against solid tumors. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses.